A randomized trial of tenapanor and phosphate binders as a dual-mechanism treatment for hyperphosphatemia in patients on maintenance dialysis (AMPLIFY)
Journal of the American Society of Nephrology | Apr 01, 2021
Fenofibrate delays the need for dialysis and reduces cardiovascular risk among patients with advanced CKD
Journal of Clinical Endocrinology and Metabolism | Mar 09, 2021
Kinetics of anti-SARS-CoV-2 IgG antibodies in hemodialysis patients 6 months after infection
Journal of the American Society of Nephrology | Mar 04, 2021
Most read this week